CALYPTE BIOMEDICAL CORP
10-Q, EX-27, 2000-08-10
LABORATORY ANALYTICAL INSTRUMENTS
Previous: CALYPTE BIOMEDICAL CORP, 10-Q, EX-10.76, 2000-08-10
Next: DIY HOME WAREHOUSE INC, 10-Q, 2000-08-10



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           4,973
<SECURITIES>                                         0
<RECEIVABLES>                                      804
<ALLOWANCES>                                      (35)
<INVENTORY>                                      1,457
<CURRENT-ASSETS>                                 8,922
<PP&E>                                           5,750
<DEPRECIATION>                                 (4,181)
<TOTAL-ASSETS>                                  10,701
<CURRENT-LIABILITIES>                            3,489
<BONDS>                                            240
                            2,276
                                          0
<COMMON>                                            25
<OTHER-SE>                                       4,641
<TOTAL-LIABILITY-AND-EQUITY>                    10,701
<SALES>                                          1,885
<TOTAL-REVENUES>                                 1,885
<CGS>                                            2,724
<TOTAL-COSTS>                                    2,724
<OTHER-EXPENSES>                                 4,638
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                (64)
<INCOME-PRETAX>                                (5,380)
<INCOME-TAX>                                       (2)
<INCOME-CONTINUING>                            (5,382)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,382)
<EPS-BASIC>                                     (0.24)
<EPS-DILUTED>                                   (0.24)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission